![New epigenetic targets identified for the potential treatment of multiple myeloma | José Carreras Leukaemia Foundation New epigenetic targets identified for the potential treatment of multiple myeloma | José Carreras Leukaemia Foundation](https://www.fcarreras.org/images/1367001/facebook.jpg)
New epigenetic targets identified for the potential treatment of multiple myeloma | José Carreras Leukaemia Foundation
![IDIBELL scientists identify the epigenetic basis of common variable immunodeficiency through the study of monozygotic twins discordant for this condit – Idibell IDIBELL scientists identify the epigenetic basis of common variable immunodeficiency through the study of monozygotic twins discordant for this condit – Idibell](https://idibell.cat/en/wp-content/uploads/sites/2/2020/05/Ballestar-Natcom1-1-1024x688.jpg)
IDIBELL scientists identify the epigenetic basis of common variable immunodeficiency through the study of monozygotic twins discordant for this condit – Idibell
![Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses | Nature Communications Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-29450-x/MediaObjects/41467_2022_29450_Fig1_HTML.png)
Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses | Nature Communications
![Seven investigators of the Josep Carreras Institute are recognized between the researchers with the most impact on world level. | Josep Carreras Leukaemia Research Institute Seven investigators of the Josep Carreras Institute are recognized between the researchers with the most impact on world level. | Josep Carreras Leukaemia Research Institute](https://www.carrerasresearch.org/images/164550/default.png)
Seven investigators of the Josep Carreras Institute are recognized between the researchers with the most impact on world level. | Josep Carreras Leukaemia Research Institute
![Epigenetic features of blood monocytes can anticipate Rheumatoid Arthritis progression | Josep Carreras Leukaemia Research Institute Epigenetic features of blood monocytes can anticipate Rheumatoid Arthritis progression | Josep Carreras Leukaemia Research Institute](https://www.carrerasresearch.org/images/202815/default.jpg)
Epigenetic features of blood monocytes can anticipate Rheumatoid Arthritis progression | Josep Carreras Leukaemia Research Institute
![The pro-B-ALL project led by Dr. Maribel Parra is selected by the i4KIDS Pediatric Hub as a finalist in its Innovation Program | Josep Carreras Leukaemia Research Institute The pro-B-ALL project led by Dr. Maribel Parra is selected by the i4KIDS Pediatric Hub as a finalist in its Innovation Program | Josep Carreras Leukaemia Research Institute](https://www.carrerasresearch.org/images/213329/default.jpg)
The pro-B-ALL project led by Dr. Maribel Parra is selected by the i4KIDS Pediatric Hub as a finalist in its Innovation Program | Josep Carreras Leukaemia Research Institute
![Carlos DE LA CALLE FABREGAT | Postdoctoral Researcher | PhD | Josep Carreras Leukaemia Research Institute, Barcelona | Epigenetics and Immune Disease Carlos DE LA CALLE FABREGAT | Postdoctoral Researcher | PhD | Josep Carreras Leukaemia Research Institute, Barcelona | Epigenetics and Immune Disease](https://i1.rgstatic.net/ii/profile.image/812148208975872-1570642630030_Q512/Carlos-De-La-Calle-Fabregat.jpg)
Carlos DE LA CALLE FABREGAT | Postdoctoral Researcher | PhD | Josep Carreras Leukaemia Research Institute, Barcelona | Epigenetics and Immune Disease
![Researchers from the Josep Carreras Institute received one of the five grants awarded worldwide by the Facebook founder's Foundation to study COVID-19 | José Carreras Leukaemia Foundation Researchers from the Josep Carreras Institute received one of the five grants awarded worldwide by the Facebook founder's Foundation to study COVID-19 | José Carreras Leukaemia Foundation](https://www.fcarreras.org/images/1360964/half_content_image_thumbnail.png)
Researchers from the Josep Carreras Institute received one of the five grants awarded worldwide by the Facebook founder's Foundation to study COVID-19 | José Carreras Leukaemia Foundation
![Showcasing Discoveries: "Cytokines, Cell Crosstalk & Epigenetic Dysregulation in Immune Disease" | Josep Carreras Leukaemia Research Institute Showcasing Discoveries: "Cytokines, Cell Crosstalk & Epigenetic Dysregulation in Immune Disease" | Josep Carreras Leukaemia Research Institute](https://www.carrerasresearch.org/showcasing-sept-dec-2021_207424.png)
Showcasing Discoveries: "Cytokines, Cell Crosstalk & Epigenetic Dysregulation in Immune Disease" | Josep Carreras Leukaemia Research Institute
![Epigenetics as a new target for treatment of bone disease in multiple myeloma | Nature Portfolio Cancer Community Epigenetics as a new target for treatment of bone disease in multiple myeloma | Nature Portfolio Cancer Community](https://images.zapnito.com/cdn-cgi/image/metadata=copyright,fit=scale-down,format=auto,sharpen=1,quality=95/https://images.zapnito.com/users/456378/avatar/medium_FCqY9BgiRuKYRtftvldA_AGG.png)
Epigenetics as a new target for treatment of bone disease in multiple myeloma | Nature Portfolio Cancer Community
![Esteban Ballestar on Twitter: "Very proud of the excellent work of the researchers in my team, presenting at the #SEI2019: Tian Li, Octavio Morante & Carlos de la Calle @delacucax https://t.co/bbYN4nhQ8N" / Esteban Ballestar on Twitter: "Very proud of the excellent work of the researchers in my team, presenting at the #SEI2019: Tian Li, Octavio Morante & Carlos de la Calle @delacucax https://t.co/bbYN4nhQ8N" /](https://pbs.twimg.com/media/D76WG1lX4AIgSt_.jpg)